Trade

with

Medtronic Inc
(NYSE: MDT)
AdChoices
66.56
+0.95
+1.45%
After Hours :
66.78
+0.22
+0.33%

Open

65.75

Previous Close

65.61

Volume (Avg)

7.88M (9.00M)

Day's Range

65.65-66.60

52Wk Range

53.33-67.11

Market Cap.

65.20B

Dividend Rate (Yield )

1.22 (1.76%)

Beta

1.12

Shares Outstanding

979.52M

P/E Ratio (EPS)

22.52 (2.95)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 17.00B

    • Net Income

    • 3.06B

    • Market Cap.

    • 65.20B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 17.35

    • PEG (Price/Earnings Growth) Ratio

    • 2.91

    • Beta

    • 1.12

    • Forward P/E

    • 16.23

    • Price/Sales

    • 3.91

    • Price/Book Value

    • 3.39

    • Price/Cash flow

    • 15.04

      • EBITDA

      • 4.93B

      • Return on Capital %

      • 8.23

      • Return on Equity %

      • 15.80

      • Return on Assets %

      • 8.23

      • Book Value/Share

      • 19.65

      • Shares Outstanding

      • 979.52M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.31 (10/1/2014)

      • Dividend Declaration Date

      • 8/21/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 73.25

        • Credit Rating

        • AA-

        • Analysts

        • 7

        • EPS Estimate

        • 3.46

        • Cashflow Estimate

        • 4.12

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 4.70

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -11.60

          • -22.64

          • Net Income

            Q/Q (last year)

          • -8.60

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 3.10

          • 4.60

          • Net Income

            5-Year Annual Average

          • 7.20

          • -1.34

          • Dividends

            5-Year Annual Average

          • 8.35

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 74.32

            • 64.08

            • Pre-Tax Margin

            • 21.14

            • 15.19

            • Net Profit Margin

            • 17.35

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 75.40

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 24.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 20.10

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.54

              • 0.34

              • Current Ratio

              • 3.82

              • 2.55

              • Quick Ratio

              • 3.25

              • 1.83

              • Interest Coverage

              • 10.42

              • 11.70

              • Leverage Ratio

              • 1.95

              • 1.86

              • Book Value/Share

              • 19.65

              • 11.67

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 21.60

                • 35.09

                • P/E Ratio 5-Year High

                • 22.71

                • 224.03

                • P/E Ratio 5-Year Low

                • 10.21

                • 60.23

                • Price/Sales Ratio

                • 3.75

                • 3.24

                • Price/Book Value

                • 3.25

                • 3.29

                • Price/Cash Flow Ratio

                • 15.04

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 15.80

                    (20.00)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 8.23

                    (10.50)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 10.69

                    (13.50)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 60.88k

                  • 34.11k

                  • Inventory Turnover

                  • 2.44

                  • 2.77

                  • Asset Turnover

                  • 0.47

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  3.81B
                  Operating Margin
                  22.42
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  15.04
                  Ownership

                  Institutional Ownership

                  87.62%

                  Top 10 Institutions

                  33.45%

                  Mutual Fund Ownership

                  48.59%

                  Float

                  88.03%

                  5% / Insider Ownership

                  0.57%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Windsor™ II Fund

                  •  

                    18,303,600

                  • 0.00

                  • 1.84

                  • Vanguard Total Stock Mkt Idx

                  •  

                    16,291,384

                  • 0.42

                  • 1.66

                  • Vanguard PrimeCap Fund

                  •  

                    15,323,952

                  • -6.13

                  • 1.54

                  • Vanguard Wellington™

                  •  

                    12,724,200

                  • 5.87

                  • 1.28

                  • Vanguard Health Care Fund

                  •  

                    12,402,000

                  • 9.39

                  • 1.25

                  • Vanguard Five Hundred Index Fund

                  •  

                    10,168,980

                  • -1.72

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    9,923,427

                  • -2.99

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    9,779,628

                  • 1.43

                  • 1.06

                  • Vanguard Dividend Growth Fund

                  •  

                    8,552,873

                  • 11.47

                  • 0.86

                  • Franklin Rising Dividends

                  •  

                    7,291,000

                  • 0.00

                  • 0.74

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    56,902,964

                  • +7.19%

                  • 5.71

                  • Vanguard Group, Inc.

                  •  

                    56,528,124

                  • +1.14%

                  • 5.68

                  • State Street Corp

                  •  

                    43,966,979

                  • +1.42%

                  • 4.42

                  • MFS Investment Management K.K.

                  •  

                    32,389,953

                  • +1.03%

                  • 3.25

                  • Barrow, Hanley, Mewhinney & Strauss LLC.

                  •  

                    32,340,234

                  • +1.96%

                  • 3.25

                  • BlackRock Fund Advisors

                  •  

                    31,547,952

                  • +3.97%

                  • 3.17

                  • PRIMECAP Management Company

                  •  

                    29,602,228

                  • -6.23%

                  • 2.97

                  • Franklin Mutual Advisers, LLC

                  •  

                    23,232,891

                  • -0.94%

                  • 2.33

                  • Northern Trust Investments, N.A.

                  •  

                    13,574,109

                  • +1.26%

                  • 1.36

                  • Harris Associates L.P.

                  •  

                    13,077,218

                  • -2.47%

                  • 1.31

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Slow Growth

                  Style

                  Large Value

                  Medtronic Inc was founded in 1949, incorporated as a Minnesota corporation in 1957. The Company is a medical technology company - alleviating pain, restoring health, and extending life for millions of people around the world. The Com...morepany develops, manufactures, and markets its medical devices in more than 140 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat and diabetes conditions. The Company functions in three operating segments that manufacture and sell device-based medical therapies: Cardiac and Vascular Group; Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group includes Cardiac Rhythm Dis...moreease Management that develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), products designed to reduce surgical site infections, information systems for the management of patients with CRDM devices, and an integrated health solutions business; Coronary which includes therapies to treat coronary artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, including a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories; The Structural Heart business offers a comprehensive line of products and therapies to treat a variety of heart valve disorders. Its products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products; The Endovascular business is comprised of a comprehensive line of products and therapies to treat aortic disease (such as aneurysms, dissections, and transections) as well as peripheral vascular disease (PVD). Its products include endovascular stent graft systems, peripheral stent and angioplasty systems, and carotid embolic protection systems for the treatment of vascular disease outside the heart. The Restorative Therapies Group includes Spine business which develops, manufactures, and markets a comprehensive line of medical devices and implants used in the treatment of the spine and musculoskeletal system. Its products and therapies treat a variety of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumors, fractures of the spine, and stenosis. Its Spine business also provides biologic solutions for the orthopedic and dental markets. Its Neuromodulation business includes implantable neurostimulation and targeted drug delivery systems for the management of chronic pain, common movement disorders, spasticity, and urologic and gastrointestinal disorders. Neurostimulation uses an implantable medical device, similar to a pacemaker, called a neurostimulator. The Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus, and orthopedic surgeries. Its Advanced Energy business includes products in the emerging field of advanced energy surgical incision technology, as well as the haemostatic sealing of soft tissue and bone. The Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management software.lessless

                  Key People

                  Mr. Omar Ishrak

                  Director/CEO/Chairman of the Board

                  Gary L. Ellis

                  CFO/Chief Accounting Officer/Executive VP

                  Michael J. Coyle

                  Executive VP/President, Divisional

                  Christopher J. O'Connell

                  Executive VP/President, Divisional

                  Hoedt Rob Ten

                  Executive VP/President, Geographical

                  • Medtronic Inc

                  • 710 Medtronic Parkway

                  • Minneapolis, MN 55432

                  • USA.Map

                  • Phone: +1 763 514-4000

                  • Fax: -

                  • medtronic.com

                  Incorporated

                  1957

                  Employees

                  49,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: